Call for Proposals

The EUNCL provides critical infrastructure and characterisation services to qualify the selected nanoparticles' physical and chemical attributes, their in vitro biological properties, and their in vivo compatibility using animal models. The EUNCL objective is to support and facilitate the regulatory review of your nanotechnologies that are intended for innovative therapies and diagnostics.

The EUNCL offers a comprehensive assay cascade aimed at evaluating the quality and safety of your nanomaterial. Moreover, the EUNCL will supply sponsors with a complete and detailed characterisation data set that enables researchers in academia, industry, and government to facilitate further development and translation of their nanotechnology strategies towards clinical applications.

The EUNCL characterisation platform aims to assess all categories of nanomedicines developed in EU.

EUNCL call for access will accept continuous application with bi-annual review campaign in April and October each year.

EUNCL call will accept all type of Med-NPs with putative application for treatment and/or diagnosis via injection or oral formulation.

If a project is selected, the EUNCL’s services will be provided at no cost to the submitting sponsor.

Guide for Applicants (PDF, 0.2 MB)

Non Disclusure Agreement (PDF, 0.2 MB)

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!

News

  • EUNCL ExBo Meeting in Liverpool
    The EUNCL ExBo met on 22nd and 23rd November 2018 at University of Liverpool to discuss the actual status of the work in the project and especially in the TNA. The CET and TNA management updated the ExBo on the on-going and the further work planned. The discussion on all questions raised during the meeting was very extensive and important decisions were taken for the last year of the project duration.
  • CLINAM 2018 with EUNCL Participation
    It was the 11th Summit of its kind. CLINAM again welcomed the participants from the community of nanomedicine, targeted drug delivery and precision medicine and bring together the pioneers and worldwide opinion leaders, not only to learn and discuss but also to develop new ideas, create new collaborative projects and shape the future of medicine.
  • Trainee position at JRC (5 months)
    The Consumer Products Safety Unit (F.2), part of Health, Consumers and Reference Materials Directorate-F at the JRC in Ispra (Italy), is looking for a trainee for the Nanobiotechnology laboratory.

More News ...